SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 27 filers reported holding SILENCE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $476,850 | -78.0% | 86,700 | -75.2% | 0.00% | -85.7% |
| Q1 2023 | $2,166,664 | -61.7% | 349,462 | -5.7% | 0.01% | -63.2% |
| Q4 2022 | $5,651,071 | +2.2% | 370,562 | -32.7% | 0.02% | -13.6% |
| Q3 2022 | $5,528,000 | +86.6% | 550,875 | +120.4% | 0.02% | +69.2% |
| Q2 2022 | $2,963,000 | -37.6% | 250,000 | 0.0% | 0.01% | -31.6% |
| Q1 2022 | $4,750,000 | -20.5% | 250,000 | 0.0% | 0.02% | -20.8% |
| Q4 2021 | $5,973,000 | – | 250,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 634,270 | $7,516,000 | 31.70% |
| Lombard Odier Asset Management (USA) Corp | 3,766,369 | $38,166,000 | 1.47% |
| GREAT POINT PARTNERS LLC | 401,449 | $4,757,000 | 1.14% |
| Frazier Life Sciences Management, L.P. | 881,173 | $10,442,000 | 0.98% |
| Deep Track Capital, LP | 951,580 | $11,276,000 | 0.74% |
| BVF INC/IL | 666,666 | $7,900,000 | 0.38% |
| Parkman Healthcare Partners LLC | 26,250 | $311,000 | 0.12% |
| CANTOR FITZGERALD, L. P. | 211,460 | $2,506,000 | 0.05% |
| AXA S.A. | 1,283,332 | $15,207,742 | 0.03% |
| WS MANAGEMENT LLLP | 25,000 | $296,000 | 0.02% |